BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 12751641)

  • 1. Targeting doxorubicin to epidermal growth factor receptors by site-specific conjugation of C225 to poly(L-glutamic acid) through a polyethylene glycol spacer.
    Vega J; Ke S; Fan Z; Wallace S; Charsangavej C; Li C
    Pharm Res; 2003 May; 20(5):826-32. PubMed ID: 12751641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(ethylene glycol)-conjugated anti-EGF receptor antibody C225 with radiometal chelator attached to the termini of polymer chains.
    Wen X; Wu QP; Lu Y; Fan Z; Charnsangavej C; Wallace S; Chow D; Li C
    Bioconjug Chem; 2001; 12(4):545-53. PubMed ID: 11459459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugation with (111)In-DTPA-poly(ethylene glycol) improves imaging of anti-EGF receptor antibody C225.
    Wen X; Wu QP; Ke S; Ellis L; Charnsangavej C; Delpassand AS; Wallace S; Li C
    J Nucl Med; 2001 Oct; 42(10):1530-7. PubMed ID: 11585869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio.
    Baabur-Cohen H; Vossen LI; Krüger HR; Eldar-Boock A; Yeini E; Landa-Rouben N; Tiram G; Wedepohl S; Markovsky E; Leor J; Calderón M; Satchi-Fainaro R
    J Control Release; 2017 Jul; 257():118-131. PubMed ID: 27374630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
    Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
    Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
    Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
    Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted delivery of methotrexate to epidermal growth factor receptor-positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates.
    Wu G; Barth RF; Yang W; Kawabata S; Zhang L; Green-Church K
    Mol Cancer Ther; 2006 Jan; 5(1):52-9. PubMed ID: 16432162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR Targeted Cetuximab-Valine-Citrulline (vc)-Doxorubicin Immunoconjugates- Loaded Bovine Serum Albumin (BSA) Nanoparticles for Colorectal Tumor Therapy.
    Ye Z; Zhang Y; Liu Y; Liu Y; Tu J; Shen Y
    Int J Nanomedicine; 2021; 16():2443-2459. PubMed ID: 33814909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
    Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
    Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Jun; 30(16):3009-19. PubMed ID: 19250665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-Responsive chimaeric pepsomes based on asymmetric poly(ethylene glycol)-b-poly(l-leucine)-b-poly(l-glutamic acid) triblock copolymer for efficient loading and active intracellular delivery of doxorubicin hydrochloride.
    Chen P; Qiu M; Deng C; Meng F; Zhang J; Cheng R; Zhong Z
    Biomacromolecules; 2015 Apr; 16(4):1322-30. PubMed ID: 25759951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of linear, Y-shaped and linear-dendritic methoxy poly(ethylene glycol)-block-polyamidoamine-block-poly(l-glutamic acid) block copolymers for doxorubicin delivery in vitro and in vivo.
    Zhang Y; Xiao C; Ding J; Li M; Chen X; Tang Z; Zhuang X; Chen X
    Acta Biomater; 2016 Aug; 40():243-253. PubMed ID: 27063495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific Conjugation of the Hinge Region for Homogeneous Preparation of Antibody Fragment-Drug Conjugate: A Case Study for Doxorubicin-PEG-anti-CD20 Fab' Synthesis.
    Zhou Z; Zhang J; Zhang Y; Ma G; Su Z
    Bioconjug Chem; 2016 Jan; 27(1):238-46. PubMed ID: 26700095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cells.
    Mamot C; Ritschard R; Küng W; Park JW; Herrmann R; Rochlitz CF
    J Drug Target; 2006 May; 14(4):215-23. PubMed ID: 16777680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Oct; 30(29):5757-66. PubMed ID: 19643472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR-Targeted Cationic Polymeric Mixed Micelles for Codelivery of Gemcitabine and miR-205 for Treating Advanced Pancreatic Cancer.
    Mondal G; Almawash S; Chaudhary AK; Mahato RI
    Mol Pharm; 2017 Sep; 14(9):3121-3133. PubMed ID: 28719220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Legumain-cleavable 4-arm poly(ethylene glycol)-doxorubicin conjugate for tumor specific delivery and release.
    Zhou H; Sun H; Lv S; Zhang D; Zhang X; Tang Z; Chen X
    Acta Biomater; 2017 May; 54():227-238. PubMed ID: 28315495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycyrrhetinic acid-modified poly(ethylene glycol)-b-poly(gamma-benzyl l-glutamate) micelles for liver targeting therapy.
    Huang W; Wang W; Wang P; Tian Q; Zhang C; Wang C; Yuan Z; Liu M; Wan H; Tang H
    Acta Biomater; 2010 Oct; 6(10):3927-35. PubMed ID: 20438873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vivo Anticancer Efficacy and Toxicity Studies of a Novel Polymer Conjugate N-Acetyl Glucosamine (NAG)-PEG-Doxorubicin for Targeted Cancer Therapy.
    Pawar S; Mahajan K; Vavia P
    AAPS PharmSciTech; 2017 Nov; 18(8):3021-3033. PubMed ID: 28497240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting cells that overexpress the epidermal growth factor receptor with polyethylene glycolated BPD verteporfin photosensitizer immunoconjugates.
    Savellano MD; Hasan T
    Photochem Photobiol; 2003 Apr; 77(4):431-9. PubMed ID: 12733655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.